Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a multi-year strategic collaboration with Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical ...
A recently published study from Fred Hutch Cancer Center dramatically expands the number of FDA-approved cancer drugs ...
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
New findings show that a fusion protein in cancer can reuse ADP as fuel alongside ATP to self-activate more quickly.
NOTE. P < .00357 represents statistical significance after the Bonferroni correction. Abbreviations: MAPK, mitogen-activated protein kinase; NA, unable to be calculated; NR, not reached; OS, overall ...
MIT researchers have identified a backup survival pathway, regulated by SRC family kinases, that enables certain tumors to ...
A new review highlights growing evidence that cyclin-dependent kinase (CDK) inhibitors—already used in over a million breast cancer patients—could benefit other cancers through novel drug combinations ...
Researchers at the University of Colorado Anschutz may have identified why many cancer patients say food suddenly tastes ...
In 1987 I attended a meeting at Cold Spring Harbor on phosphatidylinositol signaling that turned out to be pivotal for me. A few years earlier I'd helped show that a phosphatidylinositol (PI) kinase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results